Skip to content

Shortening induction time with simultaneous use of Dilapan-S and misoprostol compared with conventional labor induction in women with an unfavorable cervix.

Shortening induction time with simultaneous use of Dilapan-S and misoprostol compared with conventional labor induction in women with an unfavorable cervix. - DilaCom

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039084
Enrollment
400
Registered
2026-02-23
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of labor

Interventions

Group 1: Simultaneous use of Dilapan-S (rods), with insertion of 1–3 rods once daily into the cervical canal at 24-hour intervals, and misoprostol (tablets) up to 4 times daily at 50 µg per dose (maxi

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Indication for labor induction - 37+0 to 41+0 weeks of gestation - Singleton pregnancy - Cephalic presentation

Exclusion criteria

Exclusion criteria: - Placenta previa - Multiple pregnancy - Breech presentation - Suspected intra-amniotic infection - Premature rupture of membranes - Positive vaginal swab for Group B streptococci - Previous cesarean section or uterine surgery

Design outcomes

Primary

MeasureTime frame
Time reduction, in minutes, with combined induction compared with conventional induction, defined as the time in minutes from the start of labor induction to the onset of labor, and to the delivery of the infant. Induction progress is documented using transvaginal ultrasound examination and by assessing the Bishop score based on a vaginal examination.

Secondary

MeasureTime frame
Patient satisfaction. Assessment using an online questionnaire administered once antenatally and once postpartum.

Countries

Germany

Contacts

Public ContactJosefine Theresia Königbauer

Charité - Universitätsmedizin Berlin

josefine.koenigbauer@charite.de+49 30 450 664 139

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026